Jaclyn Freshman is an associate practicing in the firm’s health care group and a member of the drug pricing initiative. She advises health care and life sciences industry clients, including pharmaceutical and medical device manufacturers, physician and dental practices, and private equity firms, regarding a broad range of transactional, regulatory, compliance and privacy issues.
Jaclyn advises clients on compliance with health care regulatory laws, including federal and state fraud and abuse laws, HIPAA, state drug price transparency and reporting laws, and state laws governing licensure and professional practice. Additionally, Jaclyn has worked on an array of transactions including joint ventures and private equity investments. She also maintains a pro bono practice, serving as a liaison to Boston Children Hospital’s Medical Legal Partnership.
Prior to attending law school, Jaclyn worked at the Marcus Institute for Aging Research, where she developed educational tools aimed at preventing hospital-induced delirium.
- Co-author, “New York passes new health care transaction notice requirements,” Westlaw Today (May 11, 2023)
- Co-author, “4 Ways State Oversight May Change Nationwide Health Deals,” Law360 (March 23, 2023)
- Co-author, “Where do freestanding emergency departments choose to locate?” Annals of Emergency Medicine (April 2017)
- Contributor, “Hospital Elder Life Program,” The Encyclopedia of Elder Care: The Comprehensive Resource on Geriatric Health and Social Care (2017)
- JD, Stanford Law School, 2020; Gerald Gunther Prizes; Judge Thelton E. Henderson Prize; Hilmer Oehlmann, Jr. Award
- BA (History of Science, Medicine and Public Health), summa cum laude, Yale University, 2016; Phi Beta Kappa
Admissions / Qualifications
- Massachusetts, 2021